CONTE, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 134
AS - Asia 127
EU - Europa 43
SA - Sud America 9
AF - Africa 4
Totale 317
Nazione #
US - Stati Uniti d'America 129
SG - Singapore 70
CN - Cina 20
HK - Hong Kong 16
VN - Vietnam 11
DE - Germania 7
FR - Francia 6
BR - Brasile 5
IE - Irlanda 5
FI - Finlandia 4
IN - India 4
IT - Italia 4
RU - Federazione Russa 4
MX - Messico 3
AR - Argentina 2
GB - Regno Unito 2
SE - Svezia 2
TR - Turchia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
CA - Canada 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ES - Italia 1
IQ - Iraq 1
KE - Kenya 1
KR - Corea 1
LV - Lettonia 1
NL - Olanda 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
TN - Tunisia 1
UA - Ucraina 1
VE - Venezuela 1
Totale 317
Città #
Singapore 38
Hong Kong 16
Ashburn 14
New York 12
San Jose 11
Chandler 9
Council Bluffs 6
Beijing 5
Dublin 5
Ho Chi Minh City 5
Boardman 4
Helsinki 4
Lauterbourg 4
Los Angeles 4
Princeton 4
Frankfurt am Main 3
Redondo Beach 3
Atlanta 2
Düsseldorf 2
Hanoi 2
Hortolândia 2
Mumbai 2
Nanning 2
Norwalk 2
Phoenix 2
San Diego 2
Udine 2
Woodbridge 2
Amsterdam 1
Baghdad 1
Baku 1
Brooklyn 1
Browns Mills 1
Bucharest 1
Cape Town 1
Chennai 1
City of London 1
Comodoro Municipality 1
Cuenca 1
Fort Worth 1
Githunguri 1
Grand Rapids 1
Guangzhou 1
Haiphong 1
Hefei 1
Istanbul 1
Johannesburg 1
Lanús 1
Madrid 1
Manchester 1
Maracaibo 1
Mexico City 1
Milan 1
Newark 1
Nova Friburgo 1
Nuremberg 1
Oklahoma City 1
Old Bridge 1
Olomouc 1
Orem 1
Panama City 1
Paris 1
Porto Alegre 1
Riga 1
San Juan 1
Santa Clara 1
Sarıyer 1
Schiffdorf 1
Seoul 1
Shenzhen 1
Sousse 1
Thrissur 1
Thái Bình 1
Trieste 1
Uruapan 1
Vienna 1
Washington 1
Whitewater 1
Wimauma 1
Totale 220
Nome #
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines 95
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study 86
Endocrine‐based treatments in clinically‐relevant subgroups of hormone receptor‐positive/her2‐negative metastatic breast cancer: Systematic review and meta‐analysis 76
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial 72
Totale 329
Categoria #
all - tutte 1.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 4 3
2021/202224 1 9 0 2 0 0 0 1 0 4 3 4
2022/202329 6 0 1 1 4 7 0 0 7 1 1 1
2023/202431 6 1 1 0 7 11 0 0 0 0 1 4
2024/202575 2 5 0 2 6 5 4 5 13 6 8 19
2025/2026163 14 23 8 7 35 15 24 10 16 11 0 0
Totale 329